Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein

Journal of Virology

Volumn 82, Issue 8, 2008, Pages 4082-4090

  Bajaj, Bharat G ^a   Murakami, Masanao ^a   Cai, Qiliang ^a   Verma, Subhash C ^a   Lan, Ke ^a   Robertson, Erle S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 3C; MYC PROTEIN; PROTEIN P27; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; EBNA 3C, EPSTEIN BARR VIRUS; EBNA-3C, EPSTEIN-BARR VIRUS; MESSENGER RNA; MYC PROTEIN, HUMAN; S PHASE KINASE ASSOCIATED PROTEIN; VIRUS ANTIGEN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL FUNCTION; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RAT; TRANSCRIPTION REGULATION; BINDING SITE; BIOSYNTHESIS; CELL LINE; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; PROTEIN ANALYSIS; WESTERN BLOTTING;

DNA VIRUSES; HUMAN HERPESVIRUS 4; MAMMALIA;

ANTIGENS, VIRAL; BINDING SITES; BLOTTING, WESTERN; CELL LINE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPRECIPITATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION, GENETIC;

EID: 41949101446     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02500-07     Document Type: Article

References (49)

1. Reference deleted.
2. Arvanitakis, L., N. Yaseen, and S. Sharma. 1995. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J. Immunol. 155:1047-1056.
3. Ben-Bassat, H., N. Goldblum, S. Mitrani, T. Goldblum, J. M. Yoffey, M. M. Cohen, Z. Bentwich, B. Ramot, E. Klein, and G. Klein. 1977. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Im. J. Cancer 19:27-33.
4. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9558-9562.
5. Dang, C. V., K. A. O'Donnell, K. I. Zeller, T. Nguyen, R. C. Osthus, and F. Li. 2006. The c-Myc target gene network. Semin. Cancer Biol. 16:253-264.
6. Epstein, M. A., B. G. Achong, and J. H. Pope. 1967. Virus in cultured lymphoblasts from a New Guinea Burkitt lymphoma. Br. Med. J. 2:290-291.
7. Epstein, M. A., Y. M. Barr, and B. G. Achong. 1965. Studies with Burkitt's lymphoma. Wistar Inst. Symp. Monogr. 4:69-82.
8. Graham, F. L. 1977. Biological activity of tumor virus DNA. Adv. Cancer Res. 25:1-51.
9. Greenberg, R. A., R. C. O'Hagan, H. Deng, Q. Xiao, S. R. Hann, R. R. Adams, S. Lichtsteiner, L. Chin, G. B. Morin, and R. A. DePinho. 1999. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18:1219-1226.
10. Gregory, M. A., and S. R. Hann. 2000. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol. Cell. Biol. 20:2423-2435.
11. Hislop, A. D., G. S. Taylor, D. Sauce, and A. B. Rickinson. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25:587-617.
12. Jin, J., and J. W. Harper. 2003. A license to kill: transcriptional activation and enhanced turnover of Myc by the SCF(kp2) ubiquitin ligase. Cancer Cell 3:517-518.
13. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
14. Kelly, K., and U. Siebenlist. 1986. The regulation and expression of c-myc in normal and malignant cells. Annu. Rev. Immunol. 4:317-338.
15. Kelly, K., and U. Siebenlist. 1985. The role of c-myc in the proliferation of normal and neoplastic cells. J. Clin. Immunol. 5:65-77.
16. Kempkes, B., D. Pich, R. Zeidler, B. Sugden, and W. Hammerschmidt. 1995. Immortalization of human B lymphocytes by a plasmid containing 71 kilo-base pairs of Epstein-Barr virus DNA. J. Virol. 69:231-238.
17. Kim, S. Y., A. Herbst, K. A. Tworkowski, S. E. Salghetti, and W. P. Tansey. 2003. Skp2 regulates Myc protein stability and activity. Mol. Cell 11:1177-1188.
18. Klein, G. 1986. Chromosomal translocations in B-cell derived tumors. Princess Takamatsu Symp. 17:159-170.
19. Klein, G. 1986. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors. AIDS Res. 2(Suppl. 1):S167-S176.
20. Knight, J. S., M. A. Cotter, Jr., and E. S. Robertson. 2001. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter. J. Biol. Chem. 276:22971-22978.
21. Knight, J. S., and E. S. Robertson. 2004. Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity. J. Virol. 78:1981-1991.
22. Knight, J. S., N. Sharma, D. E. Kalman, and E. S. Robertson. 2004. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells. J. Virol. 78:12857-12867.
23. Knight, J. S., N. Sharma, and E. S. Robertson. 2005. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc. Natl. Acad. Sci. USA 102:18562-18566.
24. Knight, J. S., N. Sharma, and E. S. Robertson. 2005. SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Mol. Cell. Biol. 25:1749-1763.
25. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
26. Leder, P., J. Battey, G. Lenoir, C. Moulding, W. Murphy, H. Potter, T. Stewart, and R. Taub. 1983. Translocations among antibody genes in human cancer. Science 222:765-771.
27. Lüscher, B., and L. G. Larsson. 1999. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene 18:2955-2966.
28. Maruo, S., E. Johannsen, D. Illanes, A. Cooper, and E. Kieff. 2003. Epstein-Barr virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J. Virol. 77:10437-10447.
29. Mitchell, K. O., M. S. Ricci, T. Miyashita, D. T. Dicker, Z. Jin, J. C. Reed, and W. S. El-Deiry. 2000. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. Cancer Res. 60:6318-6325.
30. Moorthy, R. K., and D. A. Thorley-Lawson. 1993. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol. 67:1638-1646.
31. Nakayama, K. I., and K. Nakayama. 2005. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 16:323-333.
32. Parker, G. A., T. Crook, M. Bain, E. A. Sara, P. J. Farrell, and M. J. Allday. 1996. Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13:2541-2549.
33. Peng, M., and E. Lundgren. 1992. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene 7:1775-1782.
34. Philipp, A., A. Schneider, I. Vasrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers. 1994. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14:4032-4043.
35. Pulverer, B., A. Sommer, G. A. McArthur, R. N. Eisenman, and B. Luscher. 2000. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1. J. Cell Physiol. 183:399-410.
36. Ramsay, G., G. I. Evan, and J. M. Bishop. 1984. The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA 81:7742-7746.
37. Rickinson, A., and E. Kieff. 2002. Epstein-Barr virus, p. 2575-2627. In D. M. Knipe and P. Howley (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
38. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2447. In B. N. Fields et al. (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, PA.
39. Roizman, B. 1996. Herpesviridae, p. 2221-2231. In B. N. Fields et al. (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, PA.
40. Rottmann, S., and B. Luscher. 2006. The Mad side of the Max network: antagonizing the function of Myc and more. Curr. Top. Microbiol. Immunol. 302:63-122.
41. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13:3321-3328.
42. Skinner, G. R., A. Ahmad, and J. A. Davies. 2001. The infrequency of transmission of herpesviruses between humans and animals: postulation of an unrecognised protective host mechanism. Comp. Immunol. Microbiol. Infect. Dis. 24:255-269.
43. Tomkinson, B., E. Robertson, and E. Kieff. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:2014-2025.
44. Vervoorts, J., J. Luscher-Firzlaff, and B. Luscher. 2006. The ins and outs of MYC regulation by posttranslational mechanisms. J. Biol. Chem. 281:34725-34729.
45. von der Lehr, N., S. Johansson, and L. G. Larsson. 2003. Implication of the ubiquitin/proteasome system in Myc-regulated transcription. Cell Cycle 2:403-407.
46. von der Lehr, N., S. Johansson, S. Wu, F. Bahrain, A. Castell, C. Cetinkaya, P. Hydbring, I. Weidung, K. Nakayama, K. I. Nakayama, O. Soderberg, T. K. Kerppola, and L. G. Larsson. 2003. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol. Cell 11:1189-1200.
47. Wang, Y. W., H. S. Chang, C. H. Lin, and W. C. Yu. 2007. HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity. Int. J. Biochem. Cell Biol. 39:402-412.
48. Welcker, M., and B. E. Clurman. 2005. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4. J. Biol. Chem. 280:7654-7658.
49. Wu, K. J., C. Grandori, M. Amacker, N. Simon-Vermot, A. Polack, J. Lingner, and R. Dalla-Favera. 1999. Direct activation of TERT transcription by c-MYC. Nat. Genet. 21:220-224.